238 related articles for article (PubMed ID: 14729763)
41. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
Chang PC; Li HY; Tang HJ; Liu JW; Wang JJ; Chuang YC
J Microbiol Immunol Infect; 2007 Feb; 40(1):56-61. PubMed ID: 17332908
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
Deshpande LM; Fritsche TR; Moet GJ; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):163-70. PubMed ID: 17368801
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233
[TBL] [Abstract][Full Text] [Related]
44. [Vancomycin and high-level aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients].
Yildirim M; Sencan I; Ozdemir D; Oksüz S; Yilmaz Z; Sahin I
Mikrobiyol Bul; 2007 Apr; 41(2):271-7. PubMed ID: 17682714
[TBL] [Abstract][Full Text] [Related]
45. Isolation of Enterococcus species from infectious skin lesions.
Higaki S; Morohashi M; Yamagishi T
Drugs Exp Clin Res; 2002; 28(2-3):91-3. PubMed ID: 12224382
[TBL] [Abstract][Full Text] [Related]
46. Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India.
Mathur P; Kapil A; Chandra R; Sharma P; Das B
Indian J Med Res; 2003 Jul; 118():25-8. PubMed ID: 14748462
[TBL] [Abstract][Full Text] [Related]
47. In vitro antibacterial activities of eleven antibiotics against S. faecalis.
Hartzen SH; Frimodt-Möller N; Andreasen JJ
APMIS; 1988 Jul; 96(7):584-8. PubMed ID: 3136781
[TBL] [Abstract][Full Text] [Related]
48. Enterococcus faecium isolated from bone marrow transplant patients in Tunisia: high prevalence of antimicrobial resistance and low pathogenic power.
Abbassi MS; Achour W; Touati A; Ben Hassen A
Pathol Biol (Paris); 2009 May; 57(3):268-71. PubMed ID: 18394823
[TBL] [Abstract][Full Text] [Related]
49. Phenotypic characteristics and population genetics of Enterococcus faecalis cultured from patients in Tehran during 2000-2001.
Feizabadi MM; Aliahmadi A; Mobasheri F; Asgharzadeh A; Asadi S; Etemadi G
Can J Microbiol; 2003 Oct; 49(10):645-9. PubMed ID: 14663499
[TBL] [Abstract][Full Text] [Related]
50. Genotypic diversity and epidemiology of high-level gentamicin resistant Enterococcus in a Chinese hospital.
Qu TT; Chen YG; Yu YS; Wei ZQ; Zhou ZH; Li LJ
J Infect; 2006 Feb; 52(2):124-30. PubMed ID: 15904965
[TBL] [Abstract][Full Text] [Related]
51. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
[TBL] [Abstract][Full Text] [Related]
52. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
53. First report of mefA and msrA/msrB multidrug efflux pumps associated with blaTEM-1 β-lactamase in Enterococcus faecalis.
Chouchani C; El Salabi A; Marrakchi R; Ferchichi L; Walsh TR
Int J Infect Dis; 2012 Feb; 16(2):e104-9. PubMed ID: 22137270
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
Pfaller MA; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):459-65. PubMed ID: 17240105
[TBL] [Abstract][Full Text] [Related]
55. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
56. [Species distribution and antibiotic resistance of enterococci isolated from cattle farmers and cattles].
Mete E; Kaleli I
Mikrobiyol Bul; 2006; 40(1-2):75-80. PubMed ID: 16775960
[TBL] [Abstract][Full Text] [Related]
57. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial resistance and virulence traits of Enterococcus faecalis from primary endodontic infections.
Lins RX; de Oliveira Andrade A; Hirata Junior R; Wilson MJ; Lewis MA; Williams DW; Fidel RA
J Dent; 2013 Sep; 41(9):779-86. PubMed ID: 23851130
[TBL] [Abstract][Full Text] [Related]
59. Characterization and susceptibility patterns of clinically important Enterococcus species in eastern Nepal.
Acharya A; Khanal A; Kanungo R; Mohapatra T
Nepal Med Coll J; 2007 Dec; 9(4):250-4. PubMed ID: 18298014
[TBL] [Abstract][Full Text] [Related]
60. [Reduction of antibiotic resistance of Enterococcus faecalis in infections of the genitourinary tract].
Manfredi R; Nanetti A; Valentini R; Morelli S; Ferri M; Calza L; Chiodo F
Recenti Prog Med; 2002 Dec; 93(12):681-2. PubMed ID: 12587606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
